News
Bharat Biotech Has Stated That the Supply Price of COVAXIN to Govt of India at Rs ... - Latest Tweet by Prasar Bharati News Services
The latest Tweet by Prasar Bharati News Services states, 'Bharat Biotech has stated that the supply price of COVAXIN to Govt of India at Rs 150/dose, is a non-competitive price & clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs.'
Bharat Biotech has stated that the supply price of COVAXIN to Govt of India at Rs 150/dose, is a non-competitive price & clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs. pic.twitter.com/hTjGFF2ML6— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) June 15, 2021
(The above story first appeared on LatestLY on Jun 15, 2021 02:12 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
